Execs share progress they’ve made toward their 2025 goals

We’re a little over halfway through 2025, and it’s safe to say this year has seen a lot of movement and shifting policies in the healthcare realm.

So we decided to check in with some execs we spoke with at the beginning of the year about where they’re at with the goals they shared with us. Here’s what they had to say.

These interviews have been lightly edited for length and clarity.

Brian Evanko, president and COO, the Cigna Group

The first half of 2025 has proven that the US healthcare system remains highly dynamic, and we continue to innovate and evolve rapidly to meet the needs of our customers, clients, clinician partners, and all those we serve. We’ve accelerated our work to leverage data, advanced analytics, and emerging AI capabilities to improve our customers’ experiences as part of our “Commitment to Better” [initiative] launched earlier this year, and we just announced an AI-powered virtual assistant and a suite of other digital features to help Cigna Healthcare customers navigate their healthcare more easily. These are just examples of the actions we are taking to make healthcare simpler, more personalized, and more technologically enabled. We still have work to do, but I am proud of the progress we are making.

Chris McKee, SVP, chief strategy and business development officer, University of Texas MD Anderson Cancer Center

We’ve made progress on many key priorities that allow us to continue to deliver exceptional patient care, to define the leading edge of cancer treatment and research, and to advance the development of new and improved clinical facilities. Notable examples include:

• In May, we announced a transformational $150 million gift from Kinder Foundation to create Kinder Children’s Cancer Center, a joint venture of UT MD Anderson and Texas Children’s.
• MD Anderson launched its Institute for Cell Therapy Discovery and Innovation in November 2024 to build upon longstanding expertise and to lead the world in advancing impactful cell therapies for patients in need.
• Construction continues on our fifth research science building as well as multiple facilities in the Texas Medical Center and Greater Houston Area, and we continue planning for our future comprehensive cancer in Austin.